• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT SYSTEM Back to Search Results
Model Number AVFM10060
Device Problem Obstruction of Flow (2423)
Patient Problems Pain (1994); Stenosis (2263); Numbness (2415)
Event Date 05/31/2017
Event Type  Injury  
Manufacturer Narrative
The catalog number identified has not been cleared in the u.S.But, it is similar to the covera vascular covered stent system products that are cleared in the us.The 510 k number and pro code for the pcovera vascular covered stent system products are identified.As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.(expiry date: 09/2017).
 
Event Description
It was reported through the results of a clinical trial, approximately 4 months, 4 days post index procedure, 80% stenosis lesion was identified and re-intervention was performed using a standard pta balloon and final residual stenosis was 0%.It was further reported that approximately 4 months, 20 days post index procedure, 60% stenosis lesion was identified and re-intervention was performed using a standard pta balloon and thrombectomy/thrombolysis.Reportedly, approximately 5 months, 17 days post index procedure, 60% stenosis lesion was identified and re-intervention was performed.It was further reported that approximately 1 months, 6 months post index procedure, 50% stenosis lesion was identified and re-intervention was performed using standard pta.
 
Manufacturer Narrative
H10: manufacturing review: the lot number was provided and a lot history review was performed.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: a physical sample was not available for evaluation, and images have not been provided; the alleged stenosis could not be re produced which led to an inconclusive evaluation result.Based on the information available a definite root cause for the event reported could not be determined.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.
 
Event Description
It was reported through the results of a clinical trial that approximately four months post index procedure, stenosis in the target lesion was identified and standard pta and thrombectomy were performed.Approximately five months and one year six months post index procedure, target lesion stenosis was identified and re-intervention was performed, including pta.Approximately two years seven months post index procedure, an av fistula aneurysm was identified.The patient was admitted to the hospital and the av fistula was resected and an av graft was placed.The patient completed the study.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVERA VASCULAR COVERED STENT SYSTEM
Type of Device
VASCULAR COVERED STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key9936055
MDR Text Key187059145
Report Number9681442-2020-00076
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00801741106590
UDI-Public(01)00801741106590
Combination Product (y/n)N
PMA/PMN Number
P170042
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup
Report Date 08/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAVFM10060
Device Catalogue NumberAVFM10060
Device Lot NumberANAW3893
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/11/2020
Initial Date FDA Received04/08/2020
Supplement Dates Manufacturer Received08/06/2020
Supplement Dates FDA Received08/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASPIRIN; ASPIRIN
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age59 YR
-
-